InvestorsHub Logo
Followers 229
Posts 21457
Boards Moderated 2
Alias Born 08/03/2006

Re: None

Friday, 05/26/2017 10:21:01 AM

Friday, May 26, 2017 10:21:01 AM

Post# of 2794
Efficacy of 225Ac-labeled anti-CD33 antibody in acute myeloid leukemia (AML) correlates with peripheral blast count
Dragan Cicic1, Joseph Jurcic2 and David Scheinberg3
1Actinium Pharmaceuticals, Inc.; 2New York Presbyterian - Columbia University Medical Center; 3Memorial Sloan Kettering Cancer Center10th


International Symposium on Targeted Alpha Therapy (TAT10)

May 31, 2017

Kanazawa University, Kanazawa, Japan

http://ir.actiniumpharma.com/ir-calendar

http://nucmed.w3.kanazawa-u.ac.jp/symposium/tat10/

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ATNM News